Comparison of sirolimus vs. mycophenolate mofetil on surgical complications and wound healing in adult kidney transplantation

被引:195
作者
Valente, JF [1 ]
Hricik, D
Weigel, K
Seaman, D
Knauss, T
Siegel, CT
Bodziak, K
Schulak, JA
机构
[1] Univ Hosp Cleveland, Div Nephrol, Dept Surg, Cleveland, OH 44106 USA
[2] Univ Hosp Cleveland, Div Nephrol, Dept Med, Cleveland, OH USA
关键词
kidney transplantation; lymphocele; sirolimus; surgical complications; wound healing;
D O I
10.1034/j.1600-6143.2003.00185.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Mycophenolate mofetil (MMF) and sirolimus impair wound healing. We compared sirolimus vs. MMF to determine the relative impact on surgical complications and wound healing in adult kidney transplant recipients. This retrospective, single center study of 235 adult kidney transplants performed between 1 January 2000 and 31 January 2002 identified 158 adult, kidney-only recipients treated with tacrolimus and prednisone, from which two groups were defined: group 1 (n=84) received MMF, group 2 (n=74) received sirolimus. The incidence of fluid collections, wound problems, dehiscence, and urine leak were compared. A multivariate stepwise logistical regression analysis was performed to identify risk factors. The overall incidence of complications was 21.5%, with rates significantly lower in group 1 (2.4%) vs. group 2 (43.2%, p<0.0001). Regression analysis showed only sirolimus (p<0.001) and hypo-albuminemia (p=0.006) to independently correlate with complication occurrence. In subanalyses, lymphoceles correlated only with sirolimus (p=0.003), while other wound problems also correlated with higher body mass index (p=0.067). The use of sirolimus, tacrolimus and prednisone was associated with a greater incidence of lymphoceles, non-lymphocele perinephric fluid collections and other consequences of poor wound healing, as compared to contemporary patients treated with MMF, tacrolimus and prednisone.
引用
收藏
页码:1128 / 1134
页数:7
相关论文
共 22 条
[1]  
AKSELBAND Y, 1991, TRANSPLANT P, V23, P2833
[2]  
Bischof G, 1998, TRANSPLANT INT, V11, P277, DOI 10.1007/s001470050141
[3]  
Drafts HH, 1997, CLIN TRANSPLANT, V11, P493
[4]  
Ghasemian SMR, 1996, CLIN TRANSPLANT, V10, P218
[5]  
Halme L, 1997, TRANSPLANT INT, V10, P284
[6]   The effect of surgical site infections on outcomes and resource utilization after liver transplantation [J].
Hollenbeak, CS ;
Alfrey, EJ ;
Souba, WW .
SURGERY, 2001, 130 (02) :388-395
[7]   Obesity does not portend a bad outcome for kidney transplant recipients [J].
Howard, RJ ;
Thai, VB ;
Patton, PR ;
Hemming, AW ;
Reed, AI ;
Van der Werf, WJ ;
Fujita, S ;
Karlix, JL ;
Scornik, JC .
TRANSPLANTATION, 2002, 73 (01) :53-55
[8]   Outcomes of African American kidney transplant recipients treated with sirolimus, tacrolimus, and corticosteroids [J].
Hricik, DE ;
Anton, HAS ;
Knauss, TC ;
Rodriguez, V ;
Seaman, D ;
Siegel, C ;
Valente, J ;
Schulak, JA .
TRANSPLANTATION, 2002, 74 (02) :189-193
[9]   Safety and efficacy of TOR inhibitors and other immunosuppressive regimens in African-American renal transplant recipients [J].
Hricik, DE .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (04) :S11-S15
[10]   Are wound complications after a kidney transplant more common with modern immunosuppression? [J].
Humar, A ;
Ramcharan, T ;
Denny, R ;
Gillingham, KJ ;
Payne, WD ;
Matas, AJ .
TRANSPLANTATION, 2001, 72 (12) :1920-1923